Latest Period
Q2 2026
Security Snapshot
Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) Institutional Ownership
CUSIP: 82711P300
13F Institutional Holders and Ownership History for Q2 2026
Institutions Reporting
8
Shares (Excl. Options)
142,915
Price
$6.21
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.0001 per share
- Symbol
- SILO on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 142,915
- Total 13F value
- $886,584
- Portfolio coverage rank
- 0%
- Share change
- +142,915
- Value change
- +$886,584
- Number of holders
- 8
- Shares outstanding
- 1,253,864
- SEC-reported price per share
- $3.22
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SILO - Silo Pharma, Inc. - Common stock, par value $0.0001 per share is tracked under CUSIP 82711P300.
- 8 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Latest quarter on this page is Q2 2026.
- Additional quarter-over-quarter change detail appears as history expands.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 8 institutions filings for Q2 2026.
Security key
82711P300
Latest holder period
Q2 2026
13F holders
8
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
SILO full holder history
Silo Pharma, Inc. SEC filings
Silo Pharma, Inc. company facts
Silo Pharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 82711P300:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
SILO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC | 10% | $661,378 | 125,261 | Mitchell P. Kopin | 30 Jun 2026 | |||
| AdvisorShares Trust | 6.7% | $486,748 | 75,582 | AdvisorShares Trust | 30 Jun 2026 |
As of 30 Jun 2026, 8 institutional investors reported holding 142,915 shares of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO). This represents 11% of the company’s total 1,253,864 outstanding shares.
13F concentration
Top 8 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
11%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 6% | 75,582 | 0.06% | $469,364 | |
| FNY Investment Advisers, LLC | 3% | 37,507 | 0.08% | $232,000 | |
| CITADEL ADVISORS LLC | 1.3% | 16,800 | 0% | $104,328 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.95% | 11,956 | 0% | $74,247 | |
| VANGUARD FIDUCIARY TRUST CO | 0.07% | 874 | 0% | $5,428 | |
| Tower Research Capital LLC (TRC) | 0.01% | 181 | 0% | $1,124 | |
| HARBOUR INVESTMENTS, INC. | 0% | 14 | 0% | $87 | |
| CITIGROUP INC | 0% | 1 | 0% | $6 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
1
Latest
Q2 2026
Rows shown
1-1 of 1
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 142,915 | $886,584 | +$886,584 | $6.21 | 8 |